Eventide Healthcare & Life Sciences Fund CLASS N SHARES (ETNHX)

25.22
Net Asset Value
-0.59%
1 Day
+20.21%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.70%
Expense Ratio
--
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It is non-diversified.

Performance

1 month+4.56% 3 years--
3 months+18.40% 5 years--
1 year+57.23% Since inception+45.99%
Data through --

Peer Comparisonvs. Health

 ETNHXCategory
Performance 5-yr return--+22.35%
Expense ratio1.70%1.44%
Risk 5 year sharpe ratio--1.49
Net assets$213.5M$3.9B
Average market cap$1.6B$35.3B
Average P/E--25.2
Portfolio turnover33%33%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyEventide Funds
Fund manager & tenureFinny Kuruvilla / 2 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock85.45%
Cash12.92%
International stock1.62%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BLUE bluebird bio Inc4.37%
VCYT Veracyte Inc3.83%
TTPH Tetraphase Pharmaceuticals Inc3.70%
FPRX Five Prime Therapeutics Inc2.96%
CMRX Chimerix Inc2.88%
DYAX Dyax Corp2.85%
AGIO Agios Pharmaceuticals Inc2.58%
MDVN Medivation Inc2.42%
CEMP Cempra Inc2.42%
MGNX MacroGenics Inc2.30%

To view my watchlist

Not a member yet?

Sign up now for a free account